BVNRY BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD
- 11.966
- -0.384-3.11%
BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD News
WHO Prequalifies Bavarian Nordic's Vaccine as First Shot Against Mpox
Morocco Reports First Mpox Case Amid Ongoing Global Outbreak
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
UNICEF Issues Emergency Tender to Secure Mpox Vaccines
Spain and Germany to Donate Mpox Vaccine Doses to Africa
Trinity Stock Soars Post-market on Raised Guidance, Increased Capacity
Tonix Stock Jumps on Collaboration for Mpox Vaccine Candidate
WHO Reportedly Greenlights Mpox Vaccine Purchases Before Approval
Mpox Vaccine Maker Bavarian Nordic's Stock Jumps 10% as European Country Places Jumbo Order for Doses
Mpox Stocks in Focus as Thailand Reports First Case in Asia Linked to New Strain
Bavarian Nordic Rebounds as New Mpox Vaccine Order Boosts Outlook
Mpox Stocks Pare Recent Gains in Tuesday Trading
Bavarian Nordic Weighs Boosting Production of Mpox Vaccine Without Contracts
WHO Official Says Mpox Is 'Not the New COVID,' Calls for Coordinated Response
Why is this northern European country always able to dominate key drugs even after taking weight loss pills with smallpox vaccines?
① Denmark's GDP rebounded in the second quarter of this year, highlighting its strong dependence on the pharmaceutical industry; ② Currently, two drugs from Denmark, Novo-Nordisk's semaglutide injection and Bavarian Nordic's monkeypox vaccine, are in high demand globally.
Mpox Test Makers End Day With Huge Gains as Disease Spreads
WHO Declares Mpox a Public Health Emergency as Variant Emerges
Mpox Vaccine Developer Tonix Surges 75% Following Outbreak Spread
Bavarian Nordic to Expand Mpox Vaccine Production
Analysis
Price Target
No Data
No Data